Financhill
Back

Viking Therapeutics Quote, Financials, Valuation and Earnings

Viking Therapeutics Price Quote

$52.62
+0.03 (+1.92%)
(Updated: November 23, 2024 at 5:59 AM ET)

Viking Therapeutics Key Stats

Sell
38
Viking Therapeutics (VKTX) is a Sell

Day range:
$51.95 - $53.52
52-week range:
$11.55 - $99.41
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
6.43%

Volume:
2.6M
Avg. volume:
5.5M
1-year change:
354.93%
Market cap:
$5.9B
Revenue:
$0
EPS:
$-0.93

How Much Does Viking Therapeutics Make?

Data Unavailable

Is Viking Therapeutics Growing As A Company?

Data Unavailable

Viking Therapeutics Stock Price Performance

What Is Viking Therapeutics 52-Week High & Low?

Viking Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Viking Therapeutics?

Is Viking Therapeutics Cash Flow Positive?

  • What Is VKTX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$74.2M
  • What Is Viking Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $611.7M
  • What Is Viking Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$524.2M

Viking Therapeutics Return On Invested Capital

Data Unavailable

Viking Therapeutics Earnings Date & Stock Price

Viking Therapeutics Competitors

Viking Therapeutics Dividend Yield

Viking Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 8.12%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 9
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 112.57
Upside from Last Price: 114.05%

Major Shareholders

  • How many VKTX shares are owned by institutional investors?
    163.4M VKTX shares are owned by institutional investors
  • How many VKTX shares are owned by insiders?
    4.3M VKTX shares are owned by insiders